Surgery Today

, Volume 48, Issue 10, pp 936–943 | Cite as

Lysophosphatidylcholine as a predictor of postoperative complications after colorectal cancer surgery

  • Akihisa Matsuda
  • Marina Yamada
  • Satoshi Matsumoto
  • Nobuyuki Sakurazawa
  • Takeshi Yamada
  • Takeshi Matsutani
  • Masao Miyashita
  • Eiji Uchida
Original Article



Lysophosphatidylcholine (LPC), which is generated from phosphatidylcholine (PC) and metabolized by autotaxin (ATX), modulates immune responses via its anti-inflammatory property. We investigated the association between LPC and postoperative complications (POCs) after colorectal cancer surgery (CRC).


The subjects of this study were 43 patients who underwent surgery for CRC. Peripheral blood samples were collected preoperatively and immediately after surgery, and on postoperative days (PODs) 1, 3, 5, and 7. Patients were divided into a No-POC group (n = 33) and a POC group (n = 10). Blood LPC, IL-6, PC, and ATX levels were measured by specific enzymatic assays or ELISA.


The postoperative to preoperative LPC ratios were lowest on POD 1 in both groups. The POC group had significantly lower LPC ratios throughout the perioperative period than the No-POC group. The LPC ratios were inversely correlated with IL-6. The predictive impact of LPC ratios on POCs was demonstrated by ROC analysis (cut-off 51.2%, AUC 0.798) and multivariate analysis (OR 15.1, P = 0.01). The postoperative PC ratios decreased more after surgery in the POC group. ATX levels did not change significantly in either group.


Decreased postoperative LPC is associated with increased postoperative inflammatory response and POCs. The decreased PC supply to the circulation is a mechanism of the postoperative LPC decrease.


Colorectal cancer Lysophosphatidylcholine Postoperative complications Surgery 



This study was supported financially by a Grant-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology of Japan (15K10037: Matsuda A).

Author contributions

All authors are in agreement with the content of the manuscript. Authors’ contributions are as follows: study concept and design, AM and MY; acquisition of data, AM and NS; analysis and interpretation of data, AM, MY, SM, TY and TM; drafting of the manuscript, AM; study supervision, MM and EU.

Compliance with ethical standards

Conflict of interest

We have no conflicts of interest or financial ties to disclose.

Supplementary material

595_2018_1675_MOESM1_ESM.docx (11 kb)
Supplementary material 1 (DOCX 11 KB)
595_2018_1675_MOESM2_ESM.tif (108 kb)
Supplementary material 2 (TIF 108 KB)


  1. 1.
  2. 2.
    Oliphant R, Nicholson GA, Horgan PG, McMillan DC, Morrison DS, West of Scotland Colorectal Cancer Managed Clinical N. The impact of surgical specialisation on survival following elective colon cancer surgery. Int J Colorectal Dis. 2014;29:1143–50.CrossRefPubMedGoogle Scholar
  3. 3.
    Ghaferi AA, Birkmeyer JD, Dimick JB. Hospital volume and failure to rescue with high-risk surgery. Med Care. 2011;49:1076–81.CrossRefPubMedGoogle Scholar
  4. 4.
    Alves A, Panis Y, Mathieu P, Mantion G, Kwiatkowski F, Slim K, et al. Postoperative mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective multicenter study. Arch Surg. 2005;140:278–83 (discussion 284).CrossRefPubMedGoogle Scholar
  5. 5.
    Sjo OH, Larsen S, Lunde OC, Nesbakken A. Short term outcome after emergency and elective surgery for colon cancer. Colorectal Dis. 2009;11:733–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Artinyan A, Orcutt ST, Anaya DA, Richardson P, Chen GJ, Berger DH. Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer: a study of 12,075 patients. Ann Surg. 2015;261:497–505.CrossRefPubMedGoogle Scholar
  7. 7.
    Brown SR, Mathew R, Keding A, Marshall HC, Brown JM, Jayne DG. The impact of postoperative complications on long-term quality of life after curative colorectal cancer surgery. Ann Surg. 2014;259:916–23.CrossRefPubMedGoogle Scholar
  8. 8.
    Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg. 2011;253:890–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Richards CH, Platt JJ, Anderson JH, McKee RF, Horgan PG, McMillan DC. The impact of perioperative risk, tumor pathology and surgical complications on disease recurrence following potentially curative resection of colorectal cancer. Ann Surg. 2011;254:83–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Bulger EM, Maier RV. Lipid mediators in the pathophysiology of critical illness. Crit Care Med. 2000;28:N27–36.CrossRefPubMedGoogle Scholar
  11. 11.
    Kabarowski JH, Xu Y, Witte ON. Lysophosphatidylcholine as a ligand for immunoregulation. Biochem Pharmacol. 2002;64:161–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Kume N, Gimbrone MA Jr.. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Investig. 1994;93:907–11.CrossRefPubMedGoogle Scholar
  13. 13.
    Sevastou I, Kaffe E, Mouratis MA, Aidinis V. Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes. Biochim Biophys Acta. 2013;1831:42–60.CrossRefPubMedGoogle Scholar
  14. 14.
    Kabarowski JH, Zhu K, Le LQ, Witte ON, Xu Y. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science. 2001;293:702–5.CrossRefPubMedGoogle Scholar
  15. 15.
    Le LQ, Kabarowski JH, Weng Z, Satterthwaite AB, Harvill ET, Jensen ER, et al. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity. 2001;14:561–71.CrossRefPubMedGoogle Scholar
  16. 16.
    Park DW, Kwak DS, Park YY, Chang Y, Huh JW, Lim CM, et al. Impact of serial measurements of lysophosphatidylcholine on 28-day mortality prediction in patients admitted to the intensive care unit with severe sepsis or septic shock. J Crit Care. 2014;29:882 e885-811.CrossRefGoogle Scholar
  17. 17.
    Cho WH, Park T, Park YY, Huh JW, Lim CM, Koh Y, et al. Clinical significance of enzymatic lysophosphatidylcholine (LPC) assay data in patients with sepsis. Eur J Clin Microbiol Infect Dis. 2012;31:1805–10.CrossRefPubMedGoogle Scholar
  18. 18.
    Drobnik W, Liebisch G, Audebert FX, Frohlich D, Gluck T, Vogel P, et al. Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J Lipid Res. 2003;44:754–61.CrossRefPubMedGoogle Scholar
  19. 19.
    Yan JJ, Jung JS, Lee JE, Lee J, Huh SO, Kim HS, et al. Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat Med. 2004;10:161–7.CrossRefPubMedGoogle Scholar
  20. 20.
    McSorley ST, Khor BY, MacKay GJ, Horgan PG, McMillan DC. Examination of a CRP first approach for the detection of postoperative complications in patients undergoing surgery for colorectal cancer: a pragmatic study. Medicine (Baltimore). 2017;96:e6133.CrossRefGoogle Scholar
  21. 21.
    McSorley ST, Ramanathan ML, Horgan PG, McMillan DC. Postoperative C-reactive protein measurement predicts the severity of complications following surgery for colorectal cancer. Int J Colorectal Dis. 2015;30:913–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Rettig TC, Verwijmeren L, Dijkstra IM, Boerma D, van de Garde EM, Noordzij PG. Postoperative interleukin-6 level and early detection of complications after elective major abdominal surgery. Ann Surg. 2016;263:1207–12.CrossRefPubMedGoogle Scholar
  23. 23.
    Watt DG, McSorley ST, Park JH, Horgan PG, McMillan DC. A postoperative systemic inflammation score predicts short- and long-term outcomes in patients undergoing surgery for colorectal cancer. Ann Surg Oncol. 2017;24:1100–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Blajchman MA. Immunomodulation and blood transfusion. Am J Ther. 2002;9:389–95.CrossRefPubMedGoogle Scholar
  25. 25.
    Chimienti G, Aquilino F, Rotelli MT, Russo F, Lupo L, Pepe G. Lipoprotein(a), lipids and proinflammatory cytokines in patients undergoing major abdominal surgery. Br J Surg. 2006;93:347–53.CrossRefPubMedGoogle Scholar
  26. 26.
    Gilliland HE, Armstrong MA, Carabine U, McMurray TJ. The choice of anesthetic maintenance technique influences the antiinflammatory cytokine response to abdominal surgery. Anesth Analg. 1997;85:1394–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Veenhof AA, Sietses C, von Blomberg BM, van Hoogstraten IM, vd Pas MH, Meijerink WJ, et al. The surgical stress response and postoperative immune function after laparoscopic or conventional total mesorectal excision in rectal cancer: a randomized trial. Int J Colorectal Dis. 2011;26:53–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Sugiyama S, Kugiyama K, Ogata N, Doi H, Ota Y, Ohgushi M, et al. Biphasic regulation of transcription factor nuclear factor-kappaB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. Arterioscler Thromb Vasc Biol. 1998;18:568–76.CrossRefPubMedGoogle Scholar
  30. 30.
    Carneiro AB, Iaciura BM, Nohara LL, Lopes CD, Veas EM, Mariano VS, et al. Lysophosphatidylcholine triggers TLR2- and TLR4-mediated signaling pathways but counteracts LPS-induced NO synthesis in peritoneal macrophages by inhibiting NF-kappaB translocation and MAPK/ERK phosphorylation. PLoS One. 2013;8:e76233.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Wang H, Czura CJ, Tracey KJ. Lipid unites disparate syndromes of sepsis. Nat Med. 2004;10:124–5.CrossRefPubMedGoogle Scholar
  32. 32.
    Chen G, Li J, Qiang X, Czura CJ, Ochani M, Ochani K, Ulloa L, et al. Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis. J Lipid Res. 2005;46:623–7.CrossRefPubMedGoogle Scholar
  33. 33.
    Kabarowski JH. G2A and LPC: regulatory functions in immunity. Prostaglandins Other Lipid Mediat. 2009;89:73–81.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Menger MD, Vollmar B. Surgical trauma: hyperinflammation versus immunosuppression? Langenbecks Arch Surg. 2004;389:475–84.CrossRefPubMedGoogle Scholar
  35. 35.
    Roumen RM, Hendriks T, van der Ven-Jongekrijg J, Nieuwenhuijzen GA, Sauerwein RW, van der Meer JW, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg. 1993;218:769–76.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Mokart D, Merlin M, Sannini A, Brun JP, Delpero JR, Houvenaeghel G, et al. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth. 2005;94:767–73.CrossRefPubMedGoogle Scholar
  37. 37.
    Korner H, Nielsen HJ, Soreide JA, Nedrebo BS, Soreide K, Knapp JC. Diagnostic accuracy of C-reactive protein for intraabdominal infections after colorectal resections. J Gastrointest Surg. 2009;13:1599–606.CrossRefPubMedGoogle Scholar
  38. 38.
    Platt JJ, Ramanathan ML, Crosbie RA, Anderson JH, McKee RF, Horgan PG, et al. C-reactive protein as a predictor of postoperative infective complications after curative resection in patients with colorectal cancer. Ann Surg Oncol. 2012;19:4168–77.CrossRefPubMedGoogle Scholar
  39. 39.
    Warschkow R, Steffen T, Beutner U, Muller SA, Schmied BM, Tarantino I. Diagnostic accuracy of C-reactive protein and white blood cell counts in the early detection of inflammatory complications after open resection of colorectal cancer: a retrospective study of 1187 patients. Int J Colorectal Dis. 2012;27:1377.CrossRefPubMedGoogle Scholar
  40. 40.
    Kishimoto T, Soda Y, Matsuyama Y, Mizuno K. An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma. Clin Biochem. 2002;35:411–6.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Akihisa Matsuda
    • 1
  • Marina Yamada
    • 1
  • Satoshi Matsumoto
    • 1
  • Nobuyuki Sakurazawa
    • 1
  • Takeshi Yamada
    • 2
  • Takeshi Matsutani
    • 2
  • Masao Miyashita
    • 1
  • Eiji Uchida
    • 2
  1. 1.Department of SurgeryNippon Medical School Chiba Hokusoh HospitalInzaiJapan
  2. 2.Department of SurgeryNippon Medical SchoolTokyoJapan

Personalised recommendations